- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioArctic AB (BIOAb)
Assess today's live BioArctic AB (BIOAb) share price, performance and insights using our live Stockholm: BIOAb stock exchange data.
Analyse the historical data and BioArctic AB share price performance charts on this page. Our technical summary section provides analysis on BioArctic share price buy/sell indicators using real-time data (or discuss the BioArctic (BIOAb) stock price today with other investors in the BioArctic ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST BIOAb share price (ISIN: SE0010323311) to enhance your trading decisions with our free investment tools and resources.
What Is the BioArctic AB Share Price Today?
The BioArctic share price today is 310.4000.
What Is the Stock Symbol for BioArctic AB
The stock symbol (or 'ticker') for BioArctic AB is "BIOAb."
What Stock Exchange Does BioArctic AB Trade On?
BioArctic AB is listed and trades on the Stockholm stock exchange.
Is BioArctic AB a Good Stock to Buy?
Determining whether BioArctic AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and BioArctic AB share price performance charts on this page. Our technical summary section provides analysis on BioArctic share price buy/sell indicators using real-time data (or discuss the BioArctic (BIOAb) stock price today with other investors in the BioArctic ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST BIOAb share price (ISIN: SE0010323311) to enhance your trading decisions with our free investment tools and resources.
What Is the BioArctic AB Share Price Today?
The BioArctic share price today is 310.4000.
What Is the Stock Symbol for BioArctic AB
The stock symbol (or 'ticker') for BioArctic AB is "BIOAb."
What Stock Exchange Does BioArctic AB Trade On?
BioArctic AB is listed and trades on the Stockholm stock exchange.
Is BioArctic AB a Good Stock to Buy?
Determining whether BioArctic AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Stockholm
Currency in SEK
310.4000
+14.6000(+4.94%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
300.0000
314.0000
52 wk Range
154.4000
347.6000
BIOAb is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
300.0000314.0000
52 wk Range
154.4000347.6000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIOAb Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
295.6000
Downside
-4.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
BioArctic Company Profile
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company’s therapeutic areas encompass neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and other CNS diseases. In addition, it owns a technology platform, which develops a range of therapeutic monoclonal antibodies. Additionally, the company is developing lecanemab, which is in phase 3 clinical trials; Lecanemab that is in back-up phase 3 clinical trials; Exidavnemab, which is in phase 2 clinical trials; Lecanemab, BAN2803, and BAN2802 that are in preclinical trials; and BAN1503, PD-BT2238, ND-BT3814, and GD-BT6822, which are in discovery stage. It has research collaboration agreements with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Compare BIOAb to Peers and Sector
Metrics to compare | BIOAb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOAbPeersSector | |
|---|---|---|---|---|
P/E Ratio | 45.3x | −11.8x | −0.6x | |
PEG Ratio | 0.09 | −0.22 | 0.00 | |
Price/Book | 23.0x | 7.9x | 2.6x | |
Price / LTM Sales | 23.6x | 17.1x | 3.4x | |
Upside (Analyst Target) | −3.1% | 87.8% | 42.5% | |
Fair Value Upside | Unlock | −13.2% | 5.8% | Unlock |
Analyst Ratings
3 Buy
0 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 295.6000
(-4.77% Downside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.98 / -1.00
Revenue / Forecast
133.35M / 146.48M
People Also Watch
FAQ
What Is the BioArctic (BIOAb) Share Price Today?
The live BioArctic share price today is 310.4000
What Stock Exchange Does BioArctic (BIOAb) Trade On?
BioArctic is listed and trades on the Stockholm Stock Exchange.
What Is the Ticker (Stock Symbol) for BioArctic?
The stock symbol (also called a 'ticker') for BioArctic is "BIOAb."
What Is the Current BioArctic Market Cap?
As of today, BioArctic market capitalisation is 46.12B.
What Is BioArctic's (BIOAb) Earnings Per Share (TTM)?
The BioArctic EPS is currently 11.25 (Trailing Twelve Months).
When Is the Next BioArctic Earnings Date?
BioArctic's next earnings report will be released on 18 Feb 2026.
Is BIOAb a Buy or Sell From a Technical Analyst Perspective?
Based on today's BioArctic moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has BioArctic Stock Split?
BioArctic has split 0 times. (See the BIOAb stock split history page for full effective split date and price information.)
How Many Employees Does BioArctic Have?
BioArctic has 122 employees.
What is the current trading status of BioArctic (BIOAb)?
As of 22 Jan 2026, BioArctic (BIOAb) is trading at a price of 310.4000, with a previous close of 295.8000. The stock has fluctuated within a day range of 300.0000 to 314.0000, while its 52-week range spans from 154.4000 to 347.6000.
What Is BioArctic (BIOAb) Price Target According to Analysts?
The average 12-month price target for BioArctic is SEK295.6000, with a high estimate of SEK339 and a low estimate of SEK230. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -4.77% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.